Works matching IS 20445385 AND DT 2020 AND VI 10 AND IP 11


Results: 14
    1
    2
    3
    4
    5
    6

    Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00383-2
    By:
    • Bassan, Renato;
    • Pavoni, Chiara;
    • Intermesoli, Tamara;
    • Spinelli, Orietta;
    • Tosi, Manuela;
    • Audisio, Ernesta;
    • Marmont, Filippo;
    • Cattaneo, Chiara;
    • Borlenghi, Erika;
    • Cortelazzo, Sergio;
    • Cavattoni, Irene;
    • Fumagalli, Monica;
    • Mattei, Daniele;
    • Romani, Claudio;
    • Cortelezzi, Agostino;
    • Fracchiolla, Nicola;
    • Ciceri, Fabio;
    • Bernardi, Massimo;
    • Scattolin, Anna Maria;
    • Depaoli, Lorella
    Publication type:
    Article
    7

    Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
    By:
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Manske, Michelle K.;
    • Sarangi, Vivekananda;
    • Maurer, Matthew J.;
    • Larson, Melissa C.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • McPhail, Ellen;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • King, Rebecca L.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    8

    Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00381-4
    By:
    • Fotiou, Despina;
    • Roussou, Maria;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Dialoupi, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Giannouli, Stavroula;
    • Delavinia, Christina;
    • Efstathiou, Kostantinos;
    • Kontogiannis, Sofoklis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    9
    10
    11

    VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00378-z
    By:
    • Yu, Tengteng;
    • Chaganty, Bharat;
    • Lin, Liang;
    • Xing, Lijie;
    • Ramakrishnan, Boopathy;
    • Wen, Kenneth;
    • Hsieh, Phillip A.;
    • Wollacott, Andrew;
    • Viswanathan, Karthik;
    • Adari, Hedy;
    • Cho, Shih-Feng;
    • Li, Yuyin;
    • Chen, Hailin;
    • Yang, Wenjuan;
    • Xu, Yan;
    • An, Gang;
    • Qiu, Lugui;
    • Munshi, Nikhil;
    • Babcock, Gregory;
    • Shriver, Zachary
    Publication type:
    Article
    12

    Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
    By:
    • Kaufman, Jonathan L.;
    • Dimopoulos, Meletios A.;
    • White, Darrell;
    • Benboubker, Lotfi;
    • Cook, Gordon;
    • Leiba, Merav;
    • Morton, James;
    • Joy Ho, P.;
    • Kim, Kihyun;
    • Takezako, Naoki;
    • Moreau, Philippe;
    • Sutherland, Heather J.;
    • Magen, Hila;
    • Iida, Shinsuke;
    • Kim, Jin Seok;
    • Miles Prince, H.;
    • Cochrane, Tara;
    • Oriol, Albert;
    • Bahlis, Nizar J.;
    • Chari, Ajai
    Publication type:
    Article
    13
    14